2004
DOI: 10.1016/j.clinbiochem.2004.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-α expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(17 citation statements)
references
References 26 publications
(23 reference statements)
1
16
0
Order By: Relevance
“…This has led to numerous studies in an effort to understand the cytogenetic and molecular biology of Schistosomal SCCs. One of these studies demonstrated mutations in exons 5-8 of the p53 gene (Warren et al, 1995) while another study demonstrated alterations in the P15 and P16 genes (Swellam et al, 2004). To the best of our knowledge, the current study is the first to evaluate the expression and mutation of c-KIT in Schistosomal SCCs.…”
Section: Discussionmentioning
confidence: 87%
“…This has led to numerous studies in an effort to understand the cytogenetic and molecular biology of Schistosomal SCCs. One of these studies demonstrated mutations in exons 5-8 of the p53 gene (Warren et al, 1995) while another study demonstrated alterations in the P15 and P16 genes (Swellam et al, 2004). To the best of our knowledge, the current study is the first to evaluate the expression and mutation of c-KIT in Schistosomal SCCs.…”
Section: Discussionmentioning
confidence: 87%
“…Concomitant overexpression of p16 and p73 has oncogenic potential and affects the development and growth of breast carcinomas (Garcia et al, 2004). Alteration of p15 and p16 expression and overexpression of TGF- are found frequently in schistomal bladder cancers and squamous cell carcinomas (Swellam et al, 2004). Loss of p16 expression has prognostic value in predicting recurrence-free probability in patients affected by low-grade urothelial bladder cancer (Bartoletti et al, 2007).…”
Section: The Role Of P16mentioning
confidence: 99%
“…Deletion of the 9p21 region encoding the p16-INK4A/p14ARF/p15 tumor suppressor loci in humans results in tumor formation in a wide range of tissues (Kamb et al, 1994;Kleihues et al, 1994;Packenham et al, 1995). Loss of heterozygosity (Swellam et al, 2004), loss of homozygosity (Ranade et al, 1995;Quelle et al, 1997), and hypermethylation of the promoter (Herman et al, 1997) in the 9p21 region are all important mechanisms which have been shown to result in loss of p16 expression and promote p16-related neoplasms. Hyper-methylation of the p16 promoter region appears to occur early in neoplastic transformation before development of tumorigenicity in rat respiratory epithelium (Yamada et al, 2010).…”
Section: The Role Of P16mentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, modulation of EGFR/ TGFα expression is significant prognostic end-point biomarkers in bladder cancer and a major strategy for the anticancer and chemopreventive agents in bladder cancer. [9][10][11][12] Obstruction of VEGF and TGFα pathways inhibited the growth and metastasis of human TCC orthografts and potentiated chemotherapeutic agents, in part by inhibiting proliferation, angiogenesis, and inducing apoptosis. [13][14] Retinoids act pharmacologically to restore differentiation and inhibit growth in certain premalignant and malignant cells in vitro and in vivo, being the primary line of treatment for (acute myeloplastic) leukemia and several clinical trials were conducted including…”
Section: Introductionmentioning
confidence: 99%